Literature DB >> 8864951

A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriers.

S N Pimstone1, S M Clee, S E Gagné, L Miao, H Zhang, E A Stein, M R Hayden.   

Abstract

An Asn291Ser mutation in exon 6 of the lipoprotein lipase gene (LPL) frequently occurs in Caucasians (2-4%) and results in a partial catalytic defect. Although this mutation may be associated with low HDL cholesterol and elevated triglyceride levels, some carriers are normolipidemic and may have LPL activity in the normal range in the fasting state. To assess in vivo the influence of dietary stress on the function of this mutation, we have performed oral fat load studies on three unrelated normolipidemic Asn291Ser carriers and compared these results to five healthy controls and to a subject with a clear 50% reduction in LPL activity compared with controls. The Asn291Ser carriers exhibited a more pronounced postprandial response compared with non-carriers as evidenced by higher chylomicron triglyceride (TG) and chylomicron retinyl palmitate peaks (P = 0.03 and P = 0.02, respectively). Significantly higher area under response curves were also seen for both chylomicron triglycerides (P = 0.02) and chylomicron retinyl palmitate (P = 0.01) when compared with non-carriers. These results provide further in vivo evidence for the functional effects of this common mutation despite normal fasting lipid levels. These data suggest that even though subjects with this mutation may be normolipidemic in the fasting state, environmental stress such as an oral fat load may unmask the catalytic defect and result in significant disturbances in postprandial chylomicron metabolism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8864951

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  7 in total

1.  Lipoprotein lipase deficiency is associated with elevated acylation stimulating protein plasma levels.

Authors:  Sabina Paglialunga; Pierre Julien; Youssef Tahiri; Francois Cadelis; Jean Bergeron; Daniel Gaudet; Katherine Cianflone
Journal:  J Lipid Res       Date:  2009-02-23       Impact factor: 5.922

2.  Postprandial lipemia is modified by the presence of the APOB-516C/T polymorphism in a healthy Caucasian population.

Authors:  Pablo Pérez-Martínez; Francisco Pérez-Jiménez; José María Ordovás; Juan Antonio Moreno; Carmen Marín; Rafael Moreno; Yolanda Jiménez-Gómez; Juan Antonio Paniagua; José López-Miranda
Journal:  Lipids       Date:  2007-02-10       Impact factor: 1.880

3.  Association of polymorphisms in genes involved in lipoprotein metabolism with plasma concentrations of remnant lipoproteins and HDL subpopulations before and after hormone therapy in postmenopausal women.

Authors:  Stefania Lamon-Fava; Bela F Asztalos; Timothy D Howard; David M Reboussin; Katalin V Horvath; Ernst J Schaefer; David M Herrington
Journal:  Clin Endocrinol (Oxf)       Date:  2009-05-29       Impact factor: 3.478

4.  Rare LPL gene missense mutation in an infant with hypertriglyceridemia.

Authors:  Yuan-Yuan Qin; Ai-Qiu Wei; Qing-Wen Shan; Xiao-Ying Xian; Yang-Yang Wu; Lin Liao; Jie Yan; Zhan-Feng Lai; Fa-Quan Lin
Journal:  J Clin Lab Anal       Date:  2018-02-25       Impact factor: 2.352

5.  Assessment of the Validity and Reproducibility of a Novel Standardized Test Meal for the Study of Postprandial Triacylglycerol Concentrations.

Authors:  Nikolaos Tentolouris; Panagiotis T Kanellos; Evangelia Siami; Elpida Athanasopoulou; Nikolaos Chaviaras; Genovefa Kolovou; Petros P Sfikakis; Nikolaos Katsilambros
Journal:  Lipids       Date:  2017-06-26       Impact factor: 1.880

6.  Quantile-dependent expressivity of postprandial lipemia.

Authors:  Paul T Williams
Journal:  PLoS One       Date:  2020-02-26       Impact factor: 3.240

7.  Small and dense LDL in familial combined hyperlipidemia and N291S polymorphism of the lipoprotein lipase gene.

Authors:  Antonio López-Ruiz; María M Jarabo; María L Martínez-Triguero; Maria Morales-Suárez-Varela; Eva Solá; Celia Bañuls; Marta Casado; Antonio Hernández-Mijares
Journal:  Lipids Health Dis       Date:  2009-03-31       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.